570
Participants
Start Date
May 20, 2021
Primary Completion Date
December 8, 2021
Study Completion Date
December 8, 2021
20-valent pneumococcal conjugate vaccine (20vPnC)
20-valent pneumococcal conjugate vaccine (20vPnC)
BNT162b2
RNA-based SARS-CoV-2 vaccine (BNT162b2)
Saline
Normal saline for injection
Meridian Clinical Research, LLC, Endwell
Accellacare - Wilmington, Wilmington
Clinical Research Atlanta, Stockbridge
Clinical Neuroscience Solutions, Orlando
Indago Research & Health Center, Inc, Hialeah
Research Centers of America ( Hollywood ), Hollywood
Alliance for Multispecialty Research, LLC, Coral Gables
Acevedo Clinical Research Associates, Miami
Alliance for Multispecialty Research, LLC, Knoxville
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Memphis
Aventiv Research Inc, Columbus
Clinical Research Professionals, Chesterfield
Sundance Clinical Research, St Louis
Alliance for Multispecialty Research, LLC, Newton
Meridian Clinical Research, LLC, Omaha
DM Clinical Research, Tomball
Martin Diagnostic Clinic, Tomball
Martins Diagnostic Clinic, Tomball
IMA Clinical Research San Antonio, San Antonio
Benchmark Research, Austin
Solaris Clinical Research, Meridian
J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Anaheim Clinical Trials, LLC, Anaheim
Diablo Clinical Research, Inc., Walnut Creek
East-West Medical Research Institute, Honolulu
Wenatchee Valley Hospital, Wenatchee
Lead Sponsor
Pfizer
INDUSTRY